BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Total Non-Current Liabilities (2022 - 2026)

Updated

BioXcel Therapeutics (BTAIQ) reported Total Non-Current Liabilities of $137.15 million for Q2 2026, up 4.8% from $130.85 million a year earlier and up 3.2% from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, BioXcel Therapeutics posted Total Non-Current Liabilities of $138.59 million, up 11.0% from FY2024.

  • Total Non-Current Liabilities has a three-year compound annual growth rate of 3.0% (FY2022 to FY2025).
  • By year, Total Non-Current Liabilities came in at $124.81 million in FY2024 (-2.7%), $128.31 million in FY2023 (+1.2%) and $126.74 million in FY2022.
  • Five-year quarterly Total Non-Current Liabilities spans a low of $82.02 million in Q2 2022 and a high of $139.03 million in Q3 2023.
  • Year over year, Total Non-Current Liabilities has now increased in each of the last three quarters, with growth averaging 0.9% over the last eight quarters.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2023 (growth of 61.2%); the low point was Q3 2024 (a decline of 6.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $132.85 million (Q1 2026), $138.59 million (Q4 2025) and $130.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 137.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 137.15 Mn
Mar 31, 2026 132.85 Mn
Dec 31, 2025 138.59 Mn
Sep 30, 2025 130.11 Mn
Jun 30, 2025 130.85 Mn
Mar 31, 2025 125.46 Mn
Dec 31, 2024 124.81 Mn
Sep 30, 2024 130.16 Mn
Jun 30, 2024 130.55 Mn
Mar 31, 2024 133.46 Mn
Dec 31, 2023 128.31 Mn
Sep 30, 2023 139.03 Mn
Jun 30, 2023 132.21 Mn
Mar 31, 2023 124.52 Mn
Dec 31, 2022 126.74 Mn
Sep 30, 2022 115.94 Mn
Jun 30, 2022 82.02 Mn
API Access

BioXcel Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY